136 related articles for article (PubMed ID: 36995341)
1. Inhibition of Human Cholinesterases and in vitro β-Amyloid Aggregation by Rationally Designed Peptides.
Sanchis I; Spinelli R; Dias J; Brazzolotto X; Rietmann Á; Aimaretti F; Siano ÁS
ChemMedChem; 2023 Jun; 18(12):e202200691. PubMed ID: 36995341
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives.
Chakravarty H; Ju Y; Chen WH; Tam KY
Drug Dev Res; 2020 Apr; 81(2):242-255. PubMed ID: 31837041
[TBL] [Abstract][Full Text] [Related]
3. Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease.
Tonelli M; Catto M; Sabaté R; Francesconi V; Laurini E; Pricl S; Pisani L; Miniero DV; Liuzzi GM; Gatta E; Relini A; Gavín R; Del Rio JA; Sparatore F; Carotti A
Eur J Med Chem; 2023 Mar; 250():115169. PubMed ID: 36753881
[TBL] [Abstract][Full Text] [Related]
4. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
Ma F; Du H
Eur J Med Chem; 2017 Nov; 140():118-127. PubMed ID: 28923380
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
8. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
[TBL] [Abstract][Full Text] [Related]
10. Multitarget Therapeutic Leads for Alzheimer's Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) Aggregation.
Tonelli M; Catto M; Tasso B; Novelli F; Canu C; Iusco G; Pisani L; Stradis AD; Denora N; Sparatore A; Boido V; Carotti A; Sparatore F
ChemMedChem; 2015 Jun; 10(6):1040-53. PubMed ID: 25924599
[TBL] [Abstract][Full Text] [Related]
11. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B
Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer's agents.
El-Sayed NA; Farag AE; Ezzat MAF; Akincioglu H; Gülçin İ; Abou-Seri SM
Bioorg Chem; 2019 Dec; 93():103312. PubMed ID: 31586715
[TBL] [Abstract][Full Text] [Related]
13. New pyridine derivatives as inhibitors of acetylcholinesterase and amyloid aggregation.
Pandolfi F; De Vita D; Bortolami M; Coluccia A; Di Santo R; Costi R; Andrisano V; Alabiso F; Bergamini C; Fato R; Bartolini M; Scipione L
Eur J Med Chem; 2017 Dec; 141():197-210. PubMed ID: 29031067
[TBL] [Abstract][Full Text] [Related]
14. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
Manral A; Saini V; Meena P; Tiwari M
Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
[TBL] [Abstract][Full Text] [Related]
16. Interest of novel N-alkylpyridinium-indolizine hybrids in the field of Alzheimer's disease: Synthesis, characterization and evaluation of antioxidant activity, cholinesterase inhibition, and amyloid fibrillation interference.
Baussanne I; Firstova O; Dediu AB; Larosa C; Furdui B; Ghinea IO; Thomas A; Chierici S; Dinica R; Demeunynck M
Bioorg Chem; 2021 Nov; 116():105390. PubMed ID: 34670332
[TBL] [Abstract][Full Text] [Related]
17. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
Rouleau J; Iorga BI; Guillou C
Eur J Med Chem; 2011 Jun; 46(6):2193-205. PubMed ID: 21435752
[TBL] [Abstract][Full Text] [Related]
18. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
[TBL] [Abstract][Full Text] [Related]
19. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
[TBL] [Abstract][Full Text] [Related]
20. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]